Lost in publication: Half of all renal practice evidence is published in non-renal journals

Kidney International

Volumn 70, Issue 11, 2006, Pages 1995-2005

  Garg, A X ^a,b,c   Iansavichus, A V ^a   Kastner, M ^b   Walters, L A ^b   Wilczynski, N ^b   McKibbon, K A ^b   Yang, R C ^a   Rehman, F ^a   Haynes, R B ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Bibliometrics; Education, medical; Kidney diseases; Nephrology; Periodicals; Transplantation, renal

Indexed keywords

ARTICLE; BIBLIOMETRICS; CLASSIFICATION; CONTINUING EDUCATION; EVIDENCE BASED PRACTICE; KIDNEY DISEASE; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL PRACTICE; NEPHROLOGY; PATIENT CARE; PRIORITY JOURNAL; PUBLICATION; SCIENTIFIC LITERATURE; TRANSPLANTATION;

EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; NEPHROLOGY; PERIODICALS; RENAL DIALYSIS;

EID: 33845235463     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001896     Document Type: Article

References (220)

1. Haynes RB, Devereaux PJ, Guyatt GH. Physicians' and patients' choices in evidence based practice. BMJ 2002; 324: 1350.
2. Fones CS, Kua EH, Goh LG. 'What makes a good doctor?' - views of the medical profession and the public in setting priorities for medical education. Singapore Med J 1998; 39: 537-542.
3. Pyne T, Newman K, Leigh S et al. Meeting the information needs of clinicians for the practice of evidence-based healthcare. Health Libr Rev 1999; 16: 3-14.
4. Burke DT, DeVito MC, Schneider JC et al. Reading habits of physical medicine and rehabilitation resident physicians. Am J Phys Med Rehabil 2004; 83: 551-559.
5. Schein M, Paladugu R, Sutija VG, Wise L. What American surgeons read: a survey of a thousand Fellows of the American College of Surgeons. Curr Surg 2000; 57: 252-258.
6. U.S. National Library of Medicine. MEDLINE Fact Sheet. c2005;[cited 2006 Jun 15]. Available from http://www.nlm.nih.gov/pubs/factsheets/ medline.html.
7. Reed KL. Mapping the literature of occupational therapy. Bull Med Libr Assoc 1999; 87: 298-304.
8. Sittig DF. Identifying a core set of medical informatics serials: an analysis using the MEDLINE database. Bull Med Libr Assoc 1996; 84: 200-204.
9. Birken CS, Parkin P. In which journals will pediatricians find the best evidence for clinical practice? Pediatrics 1999; 103(Part 1): 941-947.
10. Gregoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995; 48: 159-163.
11. Juni P, Holenstein F, Sterne J et al. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 2002; 31: 115-123.
12. Haynes RB, Cotoi C, Holland J et al. Second-order peer review of the medical literature for clinical practitioners. JAMA 2006; 295: 1801-1808.
13. BMJ Publishing Group and McMaster University's Health Information Research Unit. BMJ Evidence Updates c2004; [cited 2006 Jun 15]: Available from http://bmjupdates.mcmaster.ca.
14. UpToDate. UpToDate c2006; [cited 2006 Jun 15]: Available from http://www.uptodate.com/.
15. Bickley SR, Harrison JE. How to ....find the evidence. J Orthod 2003; 30: 72-78.
16. Davidoff F, Haynes B, Sackett D, Smith R. Evidence based medicine. BMJ 1995; 310: 1085-1086.
17. Alper BS, Hand JA, Elliott SG et al. How much effort is needed to keep up with the literature relevant for primary care? J Med Libr Assoc 2004; 92: 429-437.
18. White HD, McCain KW. Bibliometrics. Annu Rev Inform Sci Technol 1989; 24: 119.
19. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15: 411-419.
20. Glick N, MacDonald I, Knoll G et al. Factors associated with publication following presentation at a transplantation meeting. Am J Transplant 2006; 6: 552-556.
21. Schena FP, Zoccali C. Bibliometric analysis of the scientific productivity of the Italian Society of Nephrology for a period of five consecutive years (1990-1994). Nephrol Dial Transplant 1996; 11: 2359-2360.
22. Helmer D, Savoie I, Green C, Kazanjian A. Evidence-based practice: extending the search to find material for the systematic review. Bull Med Libr Assoc 2001; 89: 346-352.
23. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 2005; 331: 1064-1065.
24. Adu D, Cockwell P, Ives NJ et al. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ 2003; 326: 789.
25. Albers M, Romiti M, Braganca Pereira CA et al. A meta-analysis of infrainguinal arterial reconstruction in patients with end-stage renal disease. Eur J Vasc Endovasc Surg 2001; 22: 294-300.
26. Alonso A, Lau J, Jaber BL et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 2004; 43: 1-9.
27. Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev 2005; 2: CD005283.
28. Bagshaw SM, Ghali WA. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med 2004; 2: 38.
29. Bagshaw SM, Ghali WA. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch Intern Med 2005; 165: 1087-1093.
30. Bakris GL, Weir MR, Secic M et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 2004; 65: 1991-2002.
31. Besarab A, Reyes CM, Hornberger J. Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients. Am J Kidney Dis 2002; 40: 439-446.
32. Birck R, Krzossok S, Markowetz F et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: 598-603.
33. Casas JP, Chua W, Loukogeorgakis S et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366: 2026-2033.
34. Bown MJ, Norwood MG, Sayers RD. The management of abdominal aortic aneurysms in patients with concurrent renal impairment. Eur J Vasc Endovasc Surg 2005; 30: 1-11.
35. Cheema BS, Singh MA. Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Nephrol 2005; 25: 352-364.
36. Choi HK, Liu S, Merkel PA et al. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 2001; 28: 1584-1590.
37. Clase CM, Crowther MA, Ingram AJ, Cina CS. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. J Thromb Thrombolysis 2001; 11: 127-136.
38. Cody J, Daly C, Campbell M et al. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cochrane Database Syst Rev 2005; 3: CD003895.
39. Cody J, Daly C, Campbell M et al. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev 2005; 3: CD003266.
40. Daly C, Campbell M, Cody J et al. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease. Cochrane Database Syst Rev 2001; 2: CD003078.
41. Daly CD, Campbell MK, MacLeod AM et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16: 341-347.
42. Dasgupta P, Challacombe B, Compton F, Khan S. A systematic review of hand-assisted laparoscopic live donor nephrectomy. Int J Clin Pract 2004; 58: 474-478.
43. de Groot K, Adu D, Savage CO. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001; 16: 2018-2027.
44. Devereaux PJ, Schunemann HJ, Ravindran N et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA 2002; 288: 2449-2457.
45. Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J Am Soc Nephrol 1997; 8: 1739-1744.
46. Doulton TW, He FJ, MacGregor GA. Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension 2005; 45: 880-886.
47. Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv 2005; 64: 471-479.
48. Durkan AM, Hodson EM, Willis NS, Craig JC. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 2001; 59: 1919-1927.
49. Durkan A, Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 2005; 2: CD002290.
50. Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician 2004; 33: 565-567, 571.
51. Fabrizi F, Dulai G, Dixit V et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003; 18: 1071-1081.
52. Fabrizi F, Martin P, Dixit V et al. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 2004; 20: 1053-1062.
53. Fabrizi F, Martin P, Dixit V et al. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 2004; 20: 1271-1277.
54. Fabrizi F, Dulai G, Dixit V et al. Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation 2004; 77: 859-864.
55. Fabrizi F, Martin P, Dixit V et al. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005; 5: 2433-2440.
56. Fabrizi F, Martin P, Dixit V et al. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 1452-1461.
57. Fiddian P, Sabin CA, Griffiths PD. Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J Infect Dis 2002; 186(Suppl 1): S110-S115.
58. Filler G. Treatment of nephrotic syndrome in children and controlled trials. Nephrol Dial Transplant 2003; 18(Suppl 6): vi75-vi78.
59. Flanc RS, Roberts MA, Strippoli GF et al. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2004; 43: 197-208.
60. Flanc RS, Roberts MA, Strippoli GF et al. Treatment for lupus nephritis. Cochrane Database Syst Rev 2004; 1: CD002922.
61. Fouque D, Wang P, Laville M, Boissel JP. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 2000; 15: 1986-1992.
62. Fouque D, Wang P, Laville M, Boissel JP. Low protein diets for chronic renal failure in non diabetic adults. Cochrane Database Syst Rev 2001; 2: CD001892.
63. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F464-F466.
64. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-269.
65. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-524.
66. Gabardi S, Tran JL, Clarkson MR. Enteric-coated mycophenolate sodium. Ann Pharmacother 2003; 37: 1685-1693.
67. Garg AX, Suri RS, Barrowman N et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 2003; 290: 1360-1370.
68. Garofeanu CG, Weir M, Rosas-Arellano MP et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 2005; 45: 626-637.
69. Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997; 127: 337-345.
70. Gieteling EW, Rinkel GJ. Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease. J Neurol 2003; 250: 418-423.
71. Gillespie RS, Wolf FM. Intravenous iron therapy in pediatric hemodialysis patients: a meta-analysis. Pediatr Nephrol 2004; 19: 662-666.
72. Girois SB, Chapuis F, Decullier E, Revol BG. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J Clin Microbiol Infect Dis 2005; 24: 119-130.
73. Goldwasser P, Feldman JG, Barth RH. Serum prealbumin is higher in peritoneal dialysis than in hemodialysis: a meta-analysis. Kidney Int 2002; 62: 276-281.
74. Goldwasser P, Feldman JG, Emiru M, Barth RH. Effect of dialysis modality on plasma fibrinogen concentration: a meta-analysis. Am J Kidney Dis 2004; 44: 941-949.
75. Gordon I, Barkovics M, Pindoria S et al. Primary vesicoureteric reflux as a predictor of renal damage in children hospitalized with urinary tract infection: a systematic review and meta-analysis. J Am Soc Nephrol 2003; 14: 739-744.
76. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001; 134: 370-379.
77. Habashy D, Hodson EM, Craig JC. Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 2003; 18: 906-912.
78. Habashy D, Hodson E, Craig J. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 2004; 2: CD003594.
79. Hamilton RA, Kane MP, Demers J. Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysis. Pharmacotherapy 2003; 23: 909-915.
80. Handschin AE, Weber M, Demartines N, Clavien PA. Laparoscopic donor nephrectomy. Br J Surg 2003; 90: 1323-1332.
81. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004; 4: 583-595.
82. Hind D, Calvert N, McWilliams R et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327: 361.
83. Hodson EM, Jones CA, Webster AC et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005; 365: 2105-2115.
84. Hodson EM, Barclay PG, Craig JC et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2005; 4: CD003774.
85. Hodson EM, Knight JF, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2005; 1: CD001533.
86. Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 2004; 328: 1401.
87. Hollowell JG, Greenfield SP. Screening siblings for vesicoureteral reflux. J Urol 2002; 168: 2138-2141.
88. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300-1305.
89. Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens 2001; 15: 99-106.
90. Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 2003; 38: 1005-1011.
91. Huber TS, Buhler AG, Seeger JM. Evidence-based data for the hemodialysis access surgeon. Semin Dial 2004; 17: 217-223.
92. Hurot JM, Cucherat M, Haugh M, Fouque D. Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol 2002; 13: 708-714.
93. Imperiale TF, Goldfarb S, Berns JS. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol 1995; 5: 1553-1558.
94. Isenbarger DW, Kent SM, O'Malley PG. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003; 92: 1454-1458.
95. Ives NJ, Wheatley K, Stowe RL et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003; 18: 298-304.
96. Ix JH, McCulloch CE, Chertow GM. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 2004; 19: 2747-2753.
97. Jafar TH, Stark PC, Schmid CH et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001; 60: 1131-1140.
98. Jafar TH, Schmid CH, Landa M et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001; 135: 73-87.
99. Jafar TH, Stark PC, Schmid CH et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252.
100. Jafar TH, Stark PC, Schmid CH et al. The effect of angiotensin- converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int 2005; 67: 265-271.
101. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg 2005; 30: 476-488.
102. Jones M, Ibels L, Schenkel B, Zagari M. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int 2004; 65: 757-767.
103. Kandarpa K, Becker GJ, Hunink MG et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol 2001; 12: 683-695.
104. Karassa FB, Trikalinos TA, Ioannidis JP. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 2002; 46: 1563-1571.
105. Karassa FB, Trikalinos TA, Ioannidis JP. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003; 63: 1475-1482.
106. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954-961.
107. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910-1917.
108. Kellum JA, Decker M. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001; 29: 1526-1531.
109. Kellum JA, Mehta RL, Angus DC et al. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002; 62: 1855-1863.
110. Kim MJ, Bertino Jr JS, Erb TA et al. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing. J Clin Pharmacol 2004; 44: 696-707.
111. Knoll GA, Bell RC. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ 1999; 318: 1104-1107.
112. Kshirsagar AV, Poole C, Mottl A et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004; 15: 761-769.
113. Kunz R, Neumayer HH. Maintenance therapy with triple versus double immunosuppressive regimen in renal transplantation: a meta-analysis. Transplantation 1997; 63: 386-392.
114. Lanting LC, Joung IM, Mackenbach JP et al. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care 2005; 28: 2280-2288.
115. Lee A, Cooper MC, Craig JC et al. Effects of nonsteroidal antiinflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev 2004; 2: CD002765.
116. Leertouwer TC, Gussenhoven EJ, Bosch JL et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216: 78-85.
117. Lentine KL, Brennan DC. Statin use after renal transplantation: a systematic quality review of trial-based evidence. Nephrol Dial Transplant 2004; 19: 2378-2386.
118. Lim W, Cook DJ, Crowther MA. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol 2004; 15: 3192-3206.
119. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 2005; 149: 391-401.
120. Liu R, Nair D, Ix J et al. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med 2005; 20: 193-200.
121. Long CL, Raebel MA, Price DW, Magid DJ. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004; 38: 853-858.
122. MacLeod A, Grant A, Donaldson C et al. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews. Health Technol Assess 1998; 2: 1-166.
123. MacLeod AM, Campbell M, Cody JD et al. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Cochrane Database Syst Rev 2005; 3: CD003234.
124. Mahoney BA, Smith WA, Lo DS et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev 2005; 2: CD003235.
125. Mangus RS, Haag BW. Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metaanalysis. Am J Transplant 2004; 4: 1889-1896.
126. Manley HJ, Cannella CA, Bailie GR, St Peter WL. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis. Am J Kidney Dis 2005; 46: 669-680.
127. Manlucu J, Tonelli M, Ray JG et al. Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrol Dial Transplant 2005; 20: 2376-2384.
128. Manns BJ, Taub K, Richardson RM, Donaldson C. To reuse or not to reuse? An economic evaluation of hemodialyzer reuse versus conventional single-use hemodialysis for chronic hemodialysis patients. Int J Technol Assess Health Care 2002; 18: 81-93.
129. Manns B, Stevens L, Miskulin D et al. A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int 2004; 66: 1239-1247.
130. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002; 28: 877-883.
131. McCullough PA, Sandberg KR, Dumler F, Yanez JE. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 2004; 17: 205-215.
132. McMaster P, Shann F. The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med 2003; 4: 2-7.
133. Misra D, Leibowitz K, Gowda RM et al. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis. Clin Cardiol 2004; 27: 607-610.
134. Mowatt G, Vale L, Perez J et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 2003; 7: 1-174.
135. Mowatt G, Vale L, MacLeod A. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care 2004; 20: 258-268.
136. Mulay AV, Hussain N, Fergusson D, Knoll GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant 2005; 5: 1748-1756.
137. Nallamothu BK, Shojania KG, Saint S et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004; 117: 938-947.
138. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90: 916-920.
139. Narchi H. Risk of hypertension with multicystic kidney disease: a systematic review. Arch Dis Child 2005; 90: 921-924.
140. Navaneethan SD, Shrivastava R. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev 2004; 4: CD004289.
141. Needham DM, Shufelt KA, Tomlinson G et al. Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Can J Cardiol 2004; 20: 1212-1218.
142. Newman DJ, Mattock MB, Dawnay AB et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess 2005; 9: iii-163.
143. Ng DP, Tai BC, Koh D et al. Angiotensin-I converting enzyme insertion/ deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005; 48: 1008-1016.
144. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003; 114: 44-50.
145. Palmer AJ, Tucker DM, Valentine WJ et al. Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies. Nephrol Dial Transplant 2005; 20: 1103-1109.
146. Palmer S, McGregor DO, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev 2005; 2: CD005015.
147. Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 2005; 45: 638-649.
148. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65: 1366-1374.
149. Parikh CR, McSweeney P, Schrier RW. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 2005; 67: 1999-2005.
150. Park HY, Schumock GT, Pickard AS, Akhras K. A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension. Pharmacotherapy 2003; 23: 1611-1616.
151. Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 2004; 78: 1548-1556.
152. Pedrini MT, Levey AS, Lau J et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124: 627-632.
153. Perna A, Schieppati A, Zamora J et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis 2004; 44: 385-401.
154. Playford EG, Webster AC, Sorell TC, Craig JC. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database Syst Rev 2004; 3: CD004291.
155. Prakash S, Garg AX, Heidenheim AP, House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transplant 2004; 19: 2553-2558.
156. Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem 2005; 51: 1577-1586.
157. Prins I, Plotz FB, Uiterwaal CS, van Vught HJ. Low-dose dopamine in neonatal and pediatric intensive care: a systematic review. Intensive Care Med 2001; 27: 206-210.
158. Pruchnicki MC, Dasta JF. Acute renal failure in hospitalized patients: part I. Ann Pharmacother 2002; 36: 1261-1267.
159. Rabbat CG, Treleaven DJ, Russell JD et al. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003; 14: 431-439.
160. Rabindranath KS, Strippoli GF, Roderick P et al. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. Am J Kidney Dis 2005; 45: 437-447.
161. Rabindranath KS, Butler JA, MacLeod AM et al. Physical measures for treating depression in dialysis patients. Cochrane Database Syst Rev 2005; 2: CD004541.
162. Ritzau J, Hoffman RM, Tzamaloukas AH. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis. Perit Dial Int 2001; 21: 471-479.
163. Rooijens PP, Tordoir JH, Stijnen T et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg 2004; 28: 583-589.
164. Ross SD, Fahrbach K, Frame D et al. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review. Clin Ther 2003; 25: 1786-1805.
165. Ruilope LM, Segura J. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. Clin Ther 2003; 25: 3044-3064.
166. Russo MW, Goldsweig CD, Jacobson IM, Brown Jr RS. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 2003; 98: 1610-1615.
167. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111: 1487-1491.
168. Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 2002; 288: 996-1001.
169. Samuels JA, Strippoli GF, Craig JC et al. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev 2003; 4: CD003965.
170. Samuels JA, Strippoli GF, Craig JC et al. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton) 2004; 9: 177-185.
171. Scheid DC, McCarthy LH, Lawler FH et al. Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence. J Fam Pract 2001; 50: 661-668.
172. Schieppati A, Ruggenenti P, Perna A, Remuzzi G. Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol 2003; 23: 333-339.
173. Schieppati A, Perna A, Zamora J et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev 2004; 4: CD004293.
174. Shah MB, Martin JE, Schroeder TJ, First MR. The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis. Transplantation 1999; 67: 1411-1417.
175. Sharma SK, Kini A. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv 2005; 65: 386-393.
176. Sharp J, Wild MR, Gumley AI. A systematic review of psychological interventions for the treatment of nonadherence to fluid-intake restrictions in people receiving hemodialysis. Am J Kidney Dis 2005; 45: 15-27.
177. Shilliday IR, Sherif M. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev 2005; 2: CD003421.
178. Siebenhofer A, Plank J, Horvath K et al. Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials. Diabet Med 2004; 21: 18-25.
179. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 2005; 68: 2256-2263.
180. Stratton RJ, Bircher G, Fouque D et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis 2005; 46: 387-405.
181. Strippoli GF, Manno C, Schena FP. An 'evidence-based' survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis 2003; 41: 1129-1139.
182. Strippoli GF, Manno C, Schena FP, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database Syst Rev 2003; 1: CD003967.
183. Strippoli GF, Craig M, Deeks JJ et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004; 329: 828.
184. Strippoli GF, Tong A, Johnson D et al. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44: 591-603.
185. Strippoli GF, Craig JC, Manno C, Schena FP. Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized. controlled trials. J Am Soc Nephrol 2004; 15: 3154-3165.
186. Strippoli GF, Tong A, Johnson D et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; 4: CD004679.
187. Strippoli GF, Tong A, Johnson D et al. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; 4: CD004680.
188. Strippoli GF, Craig M, Craig JC. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database Syst Rev 2005; 4: CD004136.
189. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int 2002; 62: 1819-1823.
190. Suri RS, Clark WF, Barrowman N et al. Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis. Diabetes Care 2005; 28: 2556-2562.
191. Szczech LA, Berlin JA, Aradhye S et al. Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. J Am Soc Nephrol 1997; 8: 1771-1777.
192. Tacconelli E, Carmeli Y, Aizer A et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629-1638.
193. Tan KT, van Beek EJ, Brown PW et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002; 57: 617-624.
194. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40: 875-885.
195. Tooher RL, Rao MM, Scott DF et al. A systematic review of laparoscopic live-donor nephrectomy. Transplantation 2004; 78: 404-414.
196. Vale L, Cody J, Wallace S et al. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults. Cochrane Database Syst Rev 2004; 4: CD003963.
197. Vasbinder GB, Nelemans PJ, Kessels AG et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001; 135: 401-411.
198. Villeneuve E, Sunderji R. Glycoprotein IIb/IIIa inhibitors in patients with end-stage renal disease. Ann Pharmacother 2005; 39: 732-735.
199. Vimalachandra D, Craig JC, Cowell CT, Knight JF. Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 2001; 139: 560-567.
200. Vimalachandra D, Craig JC, Cowell C, Knight JF. Growth hormone for children with chronic renal failure. Cochrane Database Syst Rev 2001; 4: CD003264.
201. Vivian EM, Rubinstein GB. Pharmacologic management of diabetic nephropathy. Clin Ther 2002; 24: 1741-1756.
202. Webster AC, Playford EG, Higgins G et al. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation 2004; 77: 166-176.
203. Webster AC, Playford EG, Higgins G et al. Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev 2004; 1: CD003897.
204. Webster A, Woodroffe RC, Taylor RS et al. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev 2005; 4: CD003961.
205. Webster AC, Woodroffe RC, Taylor RS et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810.
206. Welch JL, Thomas-Hawkins C. Psycho-educational strategies to promote fluid adherence in adult hemodialysis patients: a review of intervention studies. Int J Nurs Stud 2005; 42: 597-608.
207. Wheeler D, Vimalachandra D, Hodson EM et al. Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child 2003; 88: 688-694.
208. Widemann BC, Balis FM, Kempf-Bielack B et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer 2004; 100: 2222-2232.
209. Wight JP, Chilcott JB, Holmes MW, Brewer N. Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review. Clin Transplant 2003; 17: 293-307.
210. Wilson CH, Bhatti AA, Rix DA, Manas DM. Routine intraoperative stenting for renal transplant recipients. Transplantation 2005; 80: 877-882.
211. Wilson CH, Bhatti AA, Rix DA, Manas DM. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2005; 4: CD004925.
212. Winkelmayer WC, Weinstein MC, Mittleman MA et al. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making 2002; 22: 417-430.
213. Woodroffe R, Yao GL, Meads C et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess 2005; 9: 1-194.
214. Worster A, Preyra I, Weaver B, Haines T. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Ann Emerg Med 2002; 40: 280-286.
215. Wu HM, Tang JL, Sha ZH et al. Interventions for preventing infection in nephrotic syndrome. Cochrane Database Syst Rev 2004; 2: CD003964.
216. Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005; 118: 827-832.
217. Zarazaga A, Garcia-De-Lorenzo L, Garcia-Luna PP et al. Nutritional support in chronic renal failure: systematic review. Clin Nutr 2001; 20: 291-299.
218. Zintzaras E, Stefanidis I. Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 2005; 50: 84-91.
219. Bradford SC. Documentation. DC: Public Affairs Press, 1950.
220. Bradford SC. Sources of information on specific subjects. Engineering 1934; 137: 85-86.